Lee S H, Shin W G, Lee M G, Kim N D
College of Pharmacy, Seoul National University, Korea.
Biopharm Drug Dispos. 1994 May;15(4):305-16. doi: 10.1002/bdd.2510150405.
The pharmacokinetics of azosemide were evaluated simultaneously using both arterial and venous plasma data in six rabbits after a rapid 5 s intravenous bolus dosing. Initial arterial to venous ratios at 5 s after injection were the highest with values of 81.1, 67.3, 58.7, 530, 2660, and 10.5 for rabbits 1-6, respectively. Both curves decayed, paralleling each other at the terminal phase, with the venous levels higher than the arterial levels by 15.3, 31.9, 34.1, 40.7, 30.5, and 16.5% for rabbits 1-6, respectively. An exponential term with a negative coefficient was used to account for the short and steep rising phase of venous plasma levels after injection. Detailed analysis showed significant differences in various pharmacokinetic parameters, such as initial volume of distribution, apparent volume of distribution at steady state, and mean residence time based on arterial or venous data. A plot of 1/Q (urine flow rate) versus 1/CLR (renal clearance) of azosemide yielded a straight line in six rabbits, indicating that the CLR of azosemide is urine flow dependent in rabbits.
在6只兔子快速静脉推注给药5秒后,同时使用动脉血和静脉血血浆数据评估了阿佐塞米的药代动力学。注射后5秒时,最初的动静脉比率最高,兔子1 - 6的比率分别为81.1、67.3、58.7、530、2660和10.5。两条曲线均衰减,在终末相相互平行,兔子1 - 6的静脉血水平分别比动脉血水平高15.3%、31.9%、34.1%、40.7%、30.5%和16.5%。用一个负系数的指数项来解释注射后静脉血血浆水平短而陡的上升阶段。详细分析表明,基于动脉血或静脉血数据,在各种药代动力学参数上存在显著差异,如初始分布容积、稳态表观分布容积和平均驻留时间。阿佐塞米的1/Q(尿流率)与1/CLR(肾清除率)的关系图在6只兔子中呈直线,表明阿佐塞米在兔子中的CLR取决于尿流率。